36371 |
Gastroenterology & Hepatology |
Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Success... |
GUT LIVER 2020 10.5009/gnl19011 |
장기택 |
2020 |
36370 |
Radiology, Nuclear Medicine & Medical Imaging |
Updated 10-year outcomes of percutaneous radiofrequency ablation as fi... |
EUR RADIOL 2020 10.1007/s00330-019-06575-0 |
임효근 |
2020 |
36369 |
Radiology, Nuclear Medicine & Medical Imaging |
Systematic Review of Studies Assessing the Health-Related Quality of L... |
KOREAN J RADIOL 2020 10.3348/kjr.2019.0808 |
임효근 |
2020 |
36368 |
Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging |
RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular ... |
CARDIOVASC INTER RAD 2020 10.1007/s00270-019-02394-4 |
임효근 |
2020 |
36367 |
Gastroenterology & Hepatology |
Regorafenib in previously treated advanced hepatocellular carcinoma: I... |
LIVER INT 2020 10.1111/liv.14496 |
임호영 |
2020 |
36366 |
Oncology |
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-La... |
TARGET ONCOL 2020 10.1007/s11523-020-00706-0 |
임호영 |
2020 |
36365 |
Pathology |
TPK1 as a predictive marker for the anti-tumour effects of simvastatin... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152820 |
임호영 |
2020 |
36364 |
Oncology |
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with ad... |
BRIT J CANCER 2020 10.1038/s41416-020-0802-1 |
임호영 |
2020 |
36363 |
Oncology |
Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR... |
TARGET ONCOL 2020 10.1007/s11523-019-00691-z |
임호영 |
2020 |
36362 |
Oncology |
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatoc... |
J CLIN ONCOL 2020 10.1200/JCO.19.01307 |
임호영 |
2020 |